Annals of Surgical Oncology

, Volume 25, Issue 4, pp 991–999 | Cite as

Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent

  • Hala Muaddi
  • David P. Al-Adra
  • Rob Beecroft
  • Anand Ghanekar
  • Carol-Anne Moulton
  • Adam Doyle
  • Markus Selzner
  • Alice Wei
  • Ian D. McGilvray
  • Steven Gallinger
  • David R. Grant
  • Mark S. Cattral
  • Paul D. Greig
  • John Kachura
  • Sean P. Cleary
  • Gonzalo Sapisochin
Hepatobiliary Tumors
  • 269 Downloads

Abstract

Background

Liver resection (LR) and radiofrequency ablation (RFA) are curative-intent therapies for early stages of hepatocellular carcinoma (HCC). If HCC recurs, salvage liver transplant (SLT) may constitute a treatment option.

Objective

We aimed to compare the outcomes of patients transplanted for recurrent HCC after curative-intent therapies with those transplanted as initial therapy.

Methods

We conducted a matched-control (1:1) cohort study comparing patients with HCC treated with primary liver transplant (PLT) with SLT after HCC recurrence. Matching was performed according to the size and number of viable tumors at explant pathology following liver transplant.

Results

Between November 1999 and December 2014, 687 patients with HCC were listed for transplant at our institution. A total of 559 patients were transplanted; 509 patients were treated with PLT and 50 patients were treated with SLT for HCC recurrence after primary treatment with LR (n = 25) or RFA (n = 25). The median length of follow-up from transplant was 64 months (0.5–195), and the median time from curative-intent treatment of HCC with RFA or LR to recurrence was 9.5 months (1–36) and 14.5 months (3–143), respectively (p = 0.04). The matched cohort was composed of 48 SLT patients (23 LR and 25 RFA) and 48 PLT patients. The 5-year risk of recurrence after LT was 22% in the PLT group versus 32% in the SLT group (p = 0.53), while the 5-year actuarial patient survival after PLT was 69% versus 70% in the SLT group (p = 1).

Conclusion

Liver transplant is an effective treatment for patients with HCC recurrence following RFA or LR. Outcomes are similar in both groups.

Notes

Funding

No sources of funding were used to assist in the preparation of this study.

Disclosure

Hala Muaddi, David P. Al-Adra, Rob Beecroft, Anand Ghanekar, Carol-Anne Moulton, Adam Doyle, Markus Selzner, Alice Wei, Ian D. McGilvray, Steven Gallinger, David R. Grant, Mark S. Cattral, Paul D. Greig, John Kachura, Sean P. Cleary, and Gonzalo Sapisochin have no conflicts of interest related to the current work.

Supplementary material

10434_2017_6329_MOESM1_ESM.docx (189 kb)
Supplementary material 1 (DOCX 189 kb)

References

  1. 1.
    de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. J Hepatol. 2012;56 Suppl 1:S75–87.CrossRefPubMedGoogle Scholar
  2. 2.
    Bruix J, Sherman M, Practice Guidelines Committee AeAftSoLD. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236.CrossRefPubMedGoogle Scholar
  3. 3.
    Bruix J, Sherman M, Diseases AAftSoL. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30(1):61–74.CrossRefPubMedGoogle Scholar
  5. 5.
    Mazzaferro V, Lencioni R, Majno P. Early hepatocellular carcinoma on the procrustean bed of ablation, resection, and transplantation. Semin Liver Dis. 2014;34(4):415–426.CrossRefPubMedGoogle Scholar
  6. 6.
    N’Kontchou G, Aout M, Laurent A, et al. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis. J Hepatol. 2012;56(1):160–166.CrossRefPubMedGoogle Scholar
  7. 7.
    Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234(3):961–967.CrossRefPubMedGoogle Scholar
  8. 8.
    Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82–89.CrossRefPubMedGoogle Scholar
  9. 9.
    Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30(6):1434–1440.CrossRefPubMedGoogle Scholar
  10. 10.
    Silva MF, Sapisochin G, Strasser SI, et al. Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis. Eur J Surg Oncol. 2013;39(4):386–395.CrossRefPubMedGoogle Scholar
  11. 11.
    Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl. 2005;11(10):1242–1251.CrossRefPubMedGoogle Scholar
  12. 12.
    Sapisochin G, Bilbao I, Balsells J, et al. Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg. 2010;34(9):2146–2154.CrossRefPubMedGoogle Scholar
  13. 13.
    Mazzaferro V, Chun YS, Poon RT et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol. 2008;15(4):1001–1007.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg. 2003;238(4):508–518.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg. 2002;26(2):257–263.CrossRefPubMedGoogle Scholar
  16. 16.
    Belghiti J. Resection and liver transplantation for HCC. J Gastroenterol. 2009;44 Suppl 19:132–135.CrossRefPubMedGoogle Scholar
  17. 17.
    Guerrini GP, Gerunda GE, Montalti R, et al. Results of salvage liver transplantation. Liver Int. 2014;34(6):e96–e104.CrossRefPubMedGoogle Scholar
  18. 18.
    Tamura S, Kato T, Berho M, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001;136(1):25–30.CrossRefPubMedGoogle Scholar
  19. 19.
    Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191(4):389–394.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329–338.CrossRefPubMedGoogle Scholar
  21. 21.
    Sapisochin G, Goldaracena N, Laurence JM, et al. The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: a prospective validation study. Hepatology. 2016;64(6):2077–2088.CrossRefPubMedGoogle Scholar
  22. 22.
    DuBay D, Sandroussi C, Sandhu L, et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg. 2011;253(1):166–172.CrossRefPubMedGoogle Scholar
  23. 23.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–699.CrossRefPubMedGoogle Scholar
  24. 24.
    Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14(4):203–217.CrossRefPubMedGoogle Scholar
  25. 25.
    Murali AR, Patil S, Phillips KT, Voigt M. Locoregional therapy with curative intent versus primary liver transplant for hepatocellular carcinoma: systematic review and meta-analysis. Transplantation. 2017;101(8):e249–e257.CrossRefPubMedGoogle Scholar
  26. 26.
    Roayaie S, Jibara G, Tabrizian P, et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology. 2015;62(2):440–451.CrossRefPubMedGoogle Scholar
  27. 27.
    Kim PT, Jang JH, Atenafu EG, et al. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma. Br J Surg. 2013;100(11):1516–1522.CrossRefPubMedGoogle Scholar
  28. 28.
    Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261(5):947–955.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Hala Muaddi
    • 1
  • David P. Al-Adra
    • 1
    • 3
  • Rob Beecroft
    • 2
  • Anand Ghanekar
    • 1
    • 3
  • Carol-Anne Moulton
    • 1
  • Adam Doyle
    • 3
  • Markus Selzner
    • 1
    • 3
  • Alice Wei
    • 1
  • Ian D. McGilvray
    • 1
    • 3
  • Steven Gallinger
    • 1
  • David R. Grant
    • 1
    • 3
  • Mark S. Cattral
    • 1
    • 3
  • Paul D. Greig
    • 1
    • 3
  • John Kachura
    • 2
  • Sean P. Cleary
    • 1
  • Gonzalo Sapisochin
    • 1
    • 3
  1. 1.Department of Surgery, University Health Network-Toronto General HospitalUniversity of TorontoTorontoCanada
  2. 2.Department of Radiology, University Health Network-Toronto General HospitalUniversity of TorontoTorontoCanada
  3. 3.Department of Surgery, Multi-Organ Transplant. University Health Network-Toronto General HospitalUniversity of TorontoTorontoCanada

Personalised recommendations